AQR Capital Management
HARP

AQR Capital Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

AQR Capital Management’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,695
Closed -$16K – 2313
2022
Q3 		$16K Sell
1,695
-4,120
-71% -$76.9K ﹤0.01% 2171
2022
Q2 		$111K Buy
5,815
+3,282
+130% +$85K ﹤0.01% 2079
2022
Q1 		$126K Sell
2,533
-416
-14% -$21.6K ﹤0.01% 2120
2021
Q4 		$223K Buy
+2,949
New +$201K ﹤0.01% 2058
2021
Q1 		– Sell
-3,034
Closed -$504K – 2294
2020
Q4 		$504K Buy
3,034
+790
+35% +$122K ﹤0.01% 1781
2020
Q3 		$381K Buy
+2,244
New +$324K ﹤0.01% 1836

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

AQR Capital Management's HARP Position: Q4 2022 in Review

AQR Capital Management sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q4 2022, closing a stake of 1,695 shares — an estimated $16K sold.

AQR Capital Management first reported a position in HARP in Q3 2020 and held it in 6 quarters. The position peaked at $504K in Q4 2020. 49 funds tracked by Wall St. Rank hold HARP as of Q4 2022.

  • AQR Capital Management reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • AQR Capital Management sold 1,695 Harpoon Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $16K.
  • AQR Capital Management first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q3 2020 and held it in 6 quarters.
  • AQR Capital Management's Harpoon Therapeutics, Inc. Common Stock position peaked at $504K in Q4 2020.
  • 49 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q4 2022.

Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.